Resources

Y-mAbs is no ordinary biopharmaceutical company. Like all powerful stories, ours is personal. Founder Thomas Gad launched Y-mAbs in 2015 to help families access cutting-edge therapies like the ones that were used to potentially treat his daughter in her fight against high-risk neuroblastoma. Our heritage focused in pediatric oncology has shown us that targeting some of the most difficult cancers can open a world of possibility, enabling us to potentially treat more patients and expand access to antibody-based cancer therapies.

Learn more about Y-mAbs’ ongoing clinical trials and find out how you can connect to organizations and other resources that may help.